Brian Resnick is science correspondent at Vox, joins host Krys Boyd to discuss why new GLP-1 drugs such as Ozempic and Wegovy seem to target appetite but actually work with brain chemistry.
Read moreBrian Resnick is science correspondent at Vox, joins host Krys Boyd to discuss why new GLP-1 drugs such as Ozempic and Wegovy seem to target appetite but actually work with brain chemistry.
Read more